Remove Diagnose Remove PET Scan Remove Radiation
article thumbnail

Distinguishing Rays: Understanding the Differences Between CT scans and PET Scans (Mandsaur, Neemuch, Ratlam, Shajapur, Ujjain, Burhanpur, Madhya Pradesh)

Future Teleradiology

Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Embark on a journey into the world of medical imaging as we unravel the distinctions between two powerful diagnostic tools—Computed Tomography (CT) scans and Positron Emission Tomography (PET) scans.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

Imaging Technology

We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Medical imaging is a crucial tool for diagnosing disease, identifying a course of treatment, and determining whether therapy is successful for millions of patients around the world.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

Results demonstrated high detection rates (% positive PET scans) even at low PSA levels. in Newly Diagnosed Prostate Cancer Blue Earth Diagnostics Announces Results on Clinical Factors Impacting Detection Rates from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3

article thumbnail

What to Expect During a CT Scan

Independent Imaging

It allows physicians to diagnose and treat many different health conditions, injuries, and diseases more accurately and easily. A CT (computerized tomography) scan is used to enable doctors to see clear images of the structures and tissues of your body. Diagnostic imaging plays a very important role in modern medicine.

X-ray 52
article thumbnail

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

Imaging Technology

milla1cf Tue, 05/02/2023 - 23:50 May 2, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 18F-rhPSMA-7.3 18F-rhPSMA-7.3 on behalf of the SPOTLIGHT Study Group.